Leading virologists join together to address urgent viral threat

April 7th, 2014
Causing victims to suffer severe fever and pain, chikungunya virus has reached the Caribbean and South America – and is predicted to soon cause outbreaks in the United States. For many years the virus has remained primarily in Africa, the Indian subcontinent and Southeast Asia. In response to the arrival of the virus in the Western Hemisphere, the Global Virus Network (GVN) announced today the formation of the GVN Chikungunya Task Force, comprised of top virologists from around the world.

The announcement of the new task force coincides with World Health Day. Vector-borne diseases are the theme for World Health Day 2014 which is celebrated annually on April 7. Chikungunya is a vector-borne disease that is quickly spread by mosquitoes.

"Viruses are among the leading causes of death and disability in the world. Being able to quickly bring together the most knowledgeable researchers without regards to borders and political agendas to address viral threats such as chikungunya is paramount," said Global Virus Network co-founder and scientific director Dr. Robert Gallo and director of the Institute of Human Virology at the University of Maryland School of Medicine.

The GVN Chikungunya Task Force is composed of 16 virologists representing nine countries, including the United States, the United Kingdom, France, Ireland, Sweden, Grenada, Estonia, South Africa, and Thailand. It is being led by Dr. Scott Weaver of the University of Texas Medical Branch (UTMB), Dr. John K. Fazakerley at the Pirbright Institute in the U.K., and Dr. Marc Lecuit at the Institut Pasteur in Paris. All of the participating members are affiliated with GVN Centers of Excellence. Much of the group's effort will focus on issues related to more rapid identification of infections, improved treatment options and development of an effective vaccine.

"There is every expectation that chikungunya will continue its spread from the Caribbean into Central and South America, Mexico, and eventually the United States," said Global Virus Network's Chikungunya Task Force co-chair Dr. Scott Weaver. "As we gear up to address chikungunya in the Americas, we have much to learn from other countries where the virus has been endemic for many years. And, this new global collaboration will help all countries, particularly as we prepare for vaccine trials."

Chikungunya was first described following an outbreak in southern Tanzania in 1952. Since then the virus has been indentified in dozens of countries across Asia, Europe, Africa, and now the Americas.

There is no specific antiviral drug treatment for chikungunya, which also presents as dengue another threatening mosquito-borne infection. Treatment of those infected with Chikungunya is directed primarily at relieving symptoms, which include a very high fever and joint pain. The joint pain is often very debilitating and, in some cases, persists for several months or years. Chikungunya does not cause death directly but in the presence of other comorbidities it may contribute to a fatal outcome.

A vaccine against chikungunya does not yet exist; however, it is a key focus of Dr. Weaver's work at UTMB. In addition, as the range of the virus expands, new and rapid diagnostics will be needed to differentiate chikungunya infections from other viral illnesses, and to determine where best to deploy any future vaccines.

The Caribbean's first cases of chikungunya occurred this past October. It is estimated that in those few months there have approximately 15,000 cases. With the area's high level of tourism, the virus would have many opportunities to quickly spread to other locations. In addition, there is an indication that the type of mosquito connected to the Caribbean cases is common in the United States, Mexico and parts of South America.

"The GVN Chikungunya Task Force will help speed the process to creating vaccines and much-needed diagnostic tools," said Global Virus Network's president Dr. Sharon Hrynkow. "We look forward to working with public health agencies, including the Pan American Health Organization, to prevent the spread of chikungunya and mitigate human suffering."

More information:

Provided by Global Virus Network

This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.

More news stories

Single laser stops molecular tumbling motion instantly

In the quantum world, making the simple atom behave is one thing, but making the more complex molecule behave is another story. Now Northwestern University scientists have figured out an elegant way to stop a molecule from ...

Japanese researchers develop 30-minute Ebola test

Japanese researchers said Tuesday they had developed a new method to detect the presence of the Ebola virus in 30 minutes, with technology that could allow doctors to quickly diagnose infection.

Surprising new role for calcium in sensing pain

When you accidentally touch a hot oven, you rapidly pull your hand away. Although scientists know the basic neural circuits involved in sensing and responding to such painful stimuli, they are still sorting ...

Top South America hackers rattle Peru's Cabinet

The Peruvian hackers have broken into military, police, and other sensitive government networks in Argentina, Colombia, Chile, Venezuela and Peru, defacing websites and extracting sensitive data to strut ...

Sharks off the menu and on the tourist trail in Palau

In many places swimmers might prefer to avoid sharks, but wetsuit-clad tourists in Palau clamour to dive among the predators thanks to a pioneering conservation initiative that has made them one of the country's ...